ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 305767 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 305767; 2) Community: the network communities that were significantly associated with the response to NSC 305767; 3) Molecule: the relationships between components within communities and NSC 305767; 4) MDR: the compounds that were significantly associated with the NSC 305767.

NSC Compound Enrichment Correlation
NSC 747451 3,19-Benzylidine-14-deoxy-11,12-didehydroandrographolide 0.0208632511155816 0.21486487
NSC 758664 Sirolimus [USAN] 0.0208632511155816 -0.11222335
NSC 109451 Null 0.0208632511155817 -0.14190365
NSC 117915 1H-Indole-2,3-dione, 5-methyl-,3-[2-(2-nitrophenyl)hydrazone] 0.0208632511155817 -0.25771699
NSC 12097 Resorufine 0.0208632511155817 0.35422246
NSC 123463 Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) (8CI) 0.0208632511155817 0.59579215
NSC 159631 Ergochrome AA (2,2')-5-.beta.,6-.alpha.,10-.beta.-5',6'-.alpha.,10'-.beta. 0.0208632511155817 0.32592987
NSC 180973 Tamoxifen citrate 0.0208632511155817 0.29363077
NSC 256927 CHIP 0.0208632511155817 0.43651315
NSC 26980 Mitomycin 0.0208632511155817 0.24990563
Total:106  Current:58    [First] [Prev] [Next] [Last]